Delivery Order SPE2DB20D3101-SPE2DB25FRFU0

Award Date 4/1/25
Potential Completion Date 4/2/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $38,836.92, is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of March 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product, with a ceiling value of $4,744.74 and a period of performance through February 28, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medical product, with a ceiling value of $1,541.54 and a period of performance through January 28, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,855.18, is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical program, valued at $999,999,999 and running through November 2026. The contract is for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,030.75, is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,047.50, is a delivery order for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract has an ultimate completion date of January 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $18,073.39, is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. This...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $2,047.50, is for the delivery of 4567279592 WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a completion date of February 18, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,139.49, is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of January 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, with a ceiling value of $15,110.28, is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a medical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA, which serves as a primary vehicle for providing a comprehensive...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRFU0
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $4,015.01 and is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract does not have a set-aside designation, indicating it was awarded through open competition. The contract has an ultimate completion date of April 2, 2025.

Generated 7/1/25, 2:29 PM